Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.6 - $13.67 $420,651 - $456,372
-33,385 Reduced 60.59%
21,712 $280,000
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $765,297 - $828,658
55,097 New
55,097 $765,000
Q2 2023

Aug 07, 2023

BUY
$15.57 - $17.11 $1.92 Million - $2.11 Million
123,500 New
123,500 $1.94 Million
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $936,505 - $1.07 Million
71,380 New
71,380 $977,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.